[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hip-dysplasia-congenital\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hip-dysplasia-congenital":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100506089","developmental-dysplasia-of-the-hip-observation-vs-bracing-100506089",false,"NCT05869851","Developmental Dysplasia of the Hip: Observation vs. Bracing","Comparison of Brace to Observation in Stable, Radiological Developmental Dysplasia of the Hip: A Multi-centre, International Randomized Controlled Non-inferiority Trial","Inclusion Criteria:\n\n* Patients presenting with radiological dysplasia of a clinically stable hip under three months (12 weeks) of age\n* Radiological dysplasia will be defined as a centred hip with an alpha angle between 43 and 60 degrees and a percent coverage of the femoral head (FHC) greater than 35%, as measured on ultrasound exam\n\nExclusion Criteria:\n\n* Patients presenting with radiological dysplasia older than three months (12 weeks) of age\n* Patients presenting with clinical hip instability (Ortolani or Barlow positive)\n* Patients with known or suspected neuromuscular, collagen, chromosomal or lower-extremity congenital abnormalities or syndromic-associated hip abnormalities\n* Patients who received prior treatment (i.e. Pavlik harness) for DDH","ALL","12 Weeks",{"count":19,"type":20},514,"ESTIMATED","INTERVENTIONAL",[23],"NA","Developmental dysplasia of the hip (DDH) is the most common childhood hip condition. When caught early, bracing is the most frequently used treatment; however, the brace can disrupt important mother-baby bonding time in the newborn period and present challenges to daily living. In babies with mild DDH, some studies have suggested that their hips may improve naturally as they grow and develop. This study will look at whether careful monitoring can be just as good as bracing for babies diagnosed with mild DDH less than 3 months of age, potentially avoiding unnecessary treatment. This will be the first study to look at this question with babies being treated at different hospitals in seven different countries, so the results will make an impact on children and families worldwide.",[26,27,28,29],"Developmental Dysplasia of the Hip","Hip Dysplasia","Hip Dysplasia, Congenital","Hip Dysplasia, Developmental","RECRUITING","2025-11-19",{"date":33,"type":34},"2025-11-24","ACTUAL",{"date":36,"type":34},"2024-04-25",{"date":38,"type":20},"2028-09",{"name":40,"class":41},"University of British Columbia","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":42},"100575701","clinical-and-radiological-outcomes-of-the-romax-hip-resurfacing-system-100575701","NCT06775704","Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System","Résultats Cliniques et Radiologiques du Dispositif de resurfaçage de Hanche ROMAXTM Medacta","Inclusion Criteria:\n\n* Patients eligible for hip resurfacing, suitable for the implantation of a Medacta ROMAX hip resurfacing system according to the manufacturer's defined indication for use.\n* Aged between 18 and 65 years at the time of surgery.\n* Ability and willingness to provide written informed consent for participation.\n\nExclusion Criteria:\n\n* Active infection\n* BMI \\> 40\n* Mental illness, when the known pathology is likely to compromise the patient's ability to consent, affect the patient's assessment of their progress, or complete follow-up appointments and exams.\n* Significantly deformed anatomy (at the surgeon's discretion)\n* Osteomalacia where the fixation of an uncemented implant is contraindicated\n* Active rheumatoid arthritis\n* Osteoporosis\n* Metabolic disorders likely to impair bone formation and for which the fixation of an uncemented implant is contraindicated\n* Muscle atrophy or neuromuscular disease\n* Known allergy or hypersensitivity to the implant material\n* Any patient who cannot or does not wish to give informed consent to participate in the study\n* Patients whose chances of regaining independent mobility would be compromised by known concomitant medical issues.","18 Years","65 Years",{"count":53,"type":20},150,"OBSERVATIONAL","The goal of this observational study is to collect clinical and radiological data to monitor the safety and performance of the ROMAX hip resurfacing system. The main parameter that will be measured is the rate of revisions at 10 years.",[57,28],"Arthritis (Hip)",[59],"resurfacing","2025-09-22",{"date":62,"type":34},"2025-09-25",{"date":64,"type":34},"2025-07-14",{"date":66,"type":20},"2037-04-01",{"name":68,"class":69},"Medacta International SA","INDUSTRY"]